tvaxbiomedical.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: | ||
Meta Tags
| Title | TVAX Biomedical, |
| Description | TVAX Biomedical, Inc. is a biotechnology company currently performing phase II clinical trials to test a unique natural cancer immunotherapy as a treatment for brain |
| Keywords | alternative cancer treatment,cancer immunotherapy,cancer vaccine,brain cancer,cancer,cancer clinical trial,adoptive cell therapy,astrocytoma, carcinoma,cancer cellular therapy,cancer treatment,metastatic cancer,TVAX Immunotherapy,glioblastoma,glioma |
Server Information
| WebSite | |
| Host IP | 206.188.192.199 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
tvaxbiomedical.com Valuation
|
US$2,456,950
Last updated: 2022-06-21 16:09:53
tvaxbiomedical.com has Semrush global rank of 4,307,905. tvaxbiomedical.com has an estimated worth of US$ 2,456,950, based on its estimated Ads revenue. tvaxbiomedical.com receives approximately 283,495 unique visitors each day. Its web server is located in United States, with IP address 206.188.192.199. According to SiteAdvisor, tvaxbiomedical.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,456,950 |
| Daily Ads Revenue | US$2,268 |
| Monthly Ads Revenue | US$68,039 |
| Yearly Ads Revenue | US$816,464 |
| Daily Unique Visitors | 18,900 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| tvaxbiomedical.com. | A | 3599 | IP: 206.188.192.199 |
| tvaxbiomedical.com. | NS | 7200 | NS Record: ns20.worldnic.com. |
| tvaxbiomedical.com. | NS | 7200 | NS Record: ns19.worldnic.com. |
| tvaxbiomedical.com. | MX | 3600 | MX Record: 10 d187754a.ess.barracudanetworks.com. |
| tvaxbiomedical.com. | MX | 3600 | MX Record: 20 d187754b.ess.barracudanetworks.com. |
| tvaxbiomedical.com. | TXT | 3600 | TXT Record: MS=ms58611597 |
| tvaxbiomedical.com. | TXT | 7200 | TXT Record: v=spf1 include:spf.protection.outlook.com include:spf.ess.barracudanetworks.com -all |
HtmlToTextCheckTime:2022-06-21 16:09:53
| Careers | Contact us About Us Management Board of Directors Scientific Advisors Intellectual Property The TVAX Platform Scientific Rationale Clinical Data Manufacturing Support References TVI-Brain-1 Clinical Data Clinical Development Strategy --> Pipeline TVI-Kidney-1 Additional Programs Clinical Trials --> Consumer Resources News & Events Press Releases --> In the News Scientific Publications --> Media Kit --> Events Calendar Animal Health Home TVAX Biomedical is developing a paradigm-shifting cancer treatment that offers the promise of improved clinical outcomes and low toxicity and the potential for fundamentally changing the way cancer is treated. TVAX Immunotherapy® is a unique personalized “killer” T cell treatment. TVAX Immunotherapy employs the natural ability of T cells to kill cancer cells. Activated “killer” T cells have demonstrated the ability to effectively treat numerous cancers without many of the undesirable side effects associated with radiation and |
HTTP Headers
HTTP/1.1 200 OK Server: openresty/1.17.8.2 Date: Sat, 23 Oct 2021 18:13:22 GMT Content-Type: text/html Connection: keep-alive Vary: Accept-Encoding X-Webcom-Cache-Status: BYPASS |
tvaxbiomedical.com Whois Information
Domain Name: TVAXBIOMEDICAL.COM Registry Domain ID: 34515232_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2021-07-14T08:04:02Z Creation Date: 2000-09-12T20:21:48Z Registry Expiry Date: 2024-09-12T20:21:48Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS19.WORLDNIC.COM Name Server: NS20.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T04:12:34Z <<< |